All contributors
Kevin Kip

An EconoTimes perspective

Kevin Kip

Vice President of Clinical Analytics, University of Pittsburgh

Vice President of Clinical Analytics, University of Pittsburgh Dr. Kip has experience and interest in managing large observational epidemiological studies and clinical trials, primarily in the areas of cardiovascular diseases, novel psychotherapies, and COVID-19. He also has research interests in psychoneuroimmunology, complementary and alternative medicine, and epidemiological methods.